Vancouver, British Columbia– STEMCELL Technologies has officially launched the STEMprep™ Tissue Dissociator System, a new benchtop instrument designed to automate and standardize the process of tissue dissociation—converting solid tissue into single-cell suspensions for scientific research. The company says the innovation is aimed at helping scientists boost efficiency and consistency in fields such as cancer, immunology, and regenerative medicine.
The manual process of breaking down tissue samples can be time-consuming and prone to variability, potentially affecting research outcomes. The STEMprep™ system seeks to eliminate these bottlenecks by delivering high-yield, reproducible single-cell suspensions while preserving cell functionality and integrity—key to accurate downstream analysis.
“Tissue dissociation is essential for many areas of biomedical research, but the manual steps can slow progress and introduce inconsistency,” said Dr. Allen Eaves, President and CEO of STEMCELL Technologies. “STEMprep™ provides a more efficient and reliable way to process tissue, which ultimately leads to faster and more accurate scientific discoveries.”
The instrument supports both pre-validated protocols from STEMCELL Technologies and fully customizable workflows, making it adaptable to a wide range of tissue types and research needs.
Dr. Eaves added, “As Scientists Helping Scientists, our goal is to empower labs with flexible and scalable solutions. We believe the STEMprep™ system will be a valuable asset for any team working with tissue samples, helping them optimize their time and results.”
The launch of STEMprep™ reinforces STEMCELL Technologies’ commitment to advancing research tools that support breakthroughs in complex biological systems.
